MENU
Galectin Therapeutics (GALT) Ownership - Who owns Galectin Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
153.2M
P/E Ratio
N/A
Total Cash
25.6M
Projected Growth
N/A
Total Debt
93.47M
Revenue
N/A
Risk (Beta)
-0.09
Dividend Yield
N/A
Total Cash/Share
0.41
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GALT
Capitalization
153M
P/E Ratio
N/A
Risk (Beta)
-0.09
Dividend Yield
N/A
Total Cash
25.6M
Total Cash/Share
0.41
Total Debt
93.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-84.37M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
62K
Current Ratio
1.87
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-40.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-201.24
Shares Held By Institutions
29.7M
Shares Outstanding - Current
62.3M
Total Liabilities
110M
Total Volume MTD
N/A
Value
-1
Gain YTD
46.988
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs to combat various diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4960 Peachtree Industrial Boulevard
Phone
+1 678 620-3186
Employees
14
Web
https://www.galectintherapeutics.com